Hidradenitis Suppurativa (HS) Clinical Trials

A listing of 4 Hidradenitis Suppurativa (HS) clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Hidradenitis Suppurativa (HS)

1 - 4 of 4

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 4 active clinical trials seeking participants for Hidradenitis Suppurativa (HS) research studies. The states with the highest number of trials for Hidradenitis Suppurativa (HS) participants are Florida, Ontario, California and Texas.

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06212999

Recruiting

The purpose of this study is to evaluate long-term safety and efficacy of povorcitinib in participants with moderate to severe hidradenitis suppurativa who completed the 54 weeks of study treatment within the originating parent Phase 3 studies (INCB 54707-301 \[NCT05620823\] or INCB 54707-302 \[NCT05620836\]).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/30/2025

Locations: Investigative Site US303, Phoenix, Arizona +171 locations

Investigative Site US303, Phoenix, Arizona

Investigative Site US240, Scottsdale, Arizona

Investigative Site US307, Fort Smith, Arkansas

Investigative Site US214, Rogers, Arkansas

Investigative Site US315, Laguna Niguel, California

Investigative Site US223, Los Angeles, California

Investigative Site US222, Oakland, California

Investigative Site US226, San Diego, California

Investigative Site US233, Washington, District of Columbia

Investigative Site US309, Clearwater, Florida

Investigative Site US317, Hialeah, Florida

Investigative Site US306, Hollywood, Florida

Investigative Site US320, Hollywood, Florida

Investigative Site US316, Maitland, Florida

Investigative Site US227, Margate, Florida

Investigative Site US204, Miami, Florida

Investigative Site US236, Miami, Florida

Investigative Site US321, North Miami Beach, Florida

Investigative Site US200, Ocala, Florida

Investigative Site US228, Tampa, Florida

Investigative Site US201, Tampa, Florida

Investigative Site US311, Marietta, Georgia

Investigative Site US220, West Dundee, Illinois

Investigative Site US206, Indianapolis, Indiana

Investigative Site US337, Indianapolis, Indiana

Investigative Site US341, Bowling Green, Kentucky

Investigative Site US209, Louisville, Kentucky

Investigative Site US305, Baton Rouge, Louisiana

Investigative Site US207, Metairie, Louisiana

Investigative Site US229, New Orleans, Louisiana

Investigative Site US224, Baltimore, Maryland

Investigative Site US325, Marriottsville, Maryland

Investigative Site US225, Boston, Massachusetts

Investigative Site US304, Boston, Massachusetts

Investigative Site US310, Brighton, Massachusetts

Investigative Site US221, Quincy, Massachusetts

Investigative Site US213, Fort Gratiot, Michigan

Investigative Site US217, Waterford, Michigan

Investigative Site US212, Minneapolis, Minnesota

Investigative Site US302, Saint Louis, Missouri

Investigative Site US239, Omaha, Nebraska

Investigative Site US318, Portsmouth, New Hampshire

Investigative Site US230, East Windsor, New Jersey

Investigative Site US324, Kew Gardens, New York

Investigative Site US202, New York, New York

Investigative Site US210, Rochester, New York

Investigative Site US205, Chapel Hill, North Carolina

Investigative Site US215, Bexley, Ohio

Investigative Site US339, Bexley, Ohio

Investigative Site US330, Boardman, Ohio

Investigative Site US314, Cincinnati, Ohio

Investigative Site US312, Cleveland, Ohio

Investigative Site US203, Gahanna, Ohio

Investigative Site US301, Portland, Oregon

Investigative Site US232, Murfreesboro, Tennessee

Investigative Site US235, Arlington, Texas

Investigative Site US218, Bellaire, Texas

Investigative Site US340, Bellaire, Texas

Investigative Site US238, Pflugerville, Texas

Investigative Site US300, Plano, Texas

Investigative Site US234, San Antonio, Texas

Investigative Site US313, Norfolk, Virginia

Investigative Site US308, Spokane, Washington

Investigative Site AU205, Kogarah, New South Wales

Investigative Site AU203, Kotara, New South Wales

Investigative Site AU200, Liverpool, New South Wales

Investigative Site AU206, Woolloongabba, Queensland

Investigative Site AU207, Woolloongabba, Queensland

Investigative Site AU201, Carlton, Victoria

Investigative Site AU204, Melbourne, Victoria

Investigative Site AT306, Inssbruck, Not set

Investigative Site AT303, Vienna, Not set

Investigative Site AT305, Vienna, Not set

Investigative Site BE300, Bruxelles, Not set

Investigative Site BE306, Gent, Not set

Investigative Site BE301, Ghent, Not set

Investigative Site BE302, Liege, Not set

Investigative Site BG203, Sofia, Not set

Investigative Site BG202, Sofia, Not set

Investigative Site BG200, Sofia, Not set

Investigative Site BG204, Sofia, Not set

Investigative Site BG201, Stara Zagora, Not set

Investigative Site CA202, Calgary, Alberta

Investigative Site CA204, Edmonton, Alberta

Investigative Site CA200, Surrey, British Columbia

Investigative Site CA301, Winnipeg, Manitoba

Investigative Site CA205, Fredericton, New Brunswick

Investigative Site CA304, Barrie, Ontario

Investigative Site CA308, Hamilton, Ontario

Investigative Site CA303, London, Ontario

Investigative Site CA207, Mississauga, Ontario

Investigative Site CA302, Peterborough, Ontario

Investigative Site CA208, Richmond Hill, Ontario

Investigative Site CA307, Montreal, Quebec

Investigative Site CA206, St-jérôme, Quebec

Investigative Site CA203, St. John's, Not set

Investigative Site CZ301, Ostrava - Poruba, Not set

Investigative Site CZ300, Praha 5, Not set

Investigative Site DK200, Aarhus, Not set

Investigative Site DK201, Roskilde, Not set

Investigative Site FR305, Bordeaux, Not set

Investigative Site FR303, Brest Cedex 2, Not set

Investigative Site FR205, Dijon, Not set

Investigative Site FR307, Le Mans Cedex 9, Not set

Investigative Site FR204, Lyon Cedex 03, Not set

Investigative Site FR304, Marseille Cedex 5, Not set

Investigative Site FR302, Nantes, Not set

Investigative Site FR203, Nice Cedex 3, Not set

Investigative Site FR300, Paris, Not set

Investigative Site FR206, Reims, Not set

Investigative Site FR202, Rouen Cedex, Not set

Investigative Site FR301, Saint Priest En Jarez, Not set

Investigative Site FR306, Toulouse Cedex 9, Not set

Investigative Site DE202, Berlin, Not set

Investigative Site DE203, Bochum, Not set

Investigative Site DE305, Darmstadt, Not set

Investigative Site DE201, Dessau-rosslau, Not set

Investigative Site DE302, Dresden, Not set

Investigative Site DE306, Duesseldorf, Not set

Investigative Site DE207, Erlangen, Not set

Investigative Site DE301, Frankfurt, Not set

Investigative Site DE208, Goettingen, Not set

Investigative Site DE303, Hamburg, Not set

Investigative Site DE300, Hannover, Not set

Investigative Site DE205, Heidelberg, Not set

Investigative Site DE200, Kiel, Not set

Investigative Site DE307, Memmingen, Not set

Investigative Site DE206, Merzig, Not set

Investigative Site GR300, Athens, Not set

Investigative Site GR303, Athens, Not set

Investigative Site GR302, Thessaloniki, Not set

Investigative Site IT200, Ancona, Not set

Investigative Site IT207, Catania, Not set

Investigative Site IT202, Milano, Not set

Investigative Site IT206, Pisa, Not set

Investigative Site IT205, Roma, Not set

Investigative Site IT201, Rozzano, Not set

Investigative Site JP301, Ginowan-shi, Not set

Investigative Site JP304, Itabashi-ku, Not set

Investigative Site JP305, Kurume-shi, Not set

Investigative Site JP300, Kyoto-shi, Not set

Investigative Site JP303, Niigata-shi, Not set

Investigative Site JP308, Sapporo-shi, Not set

Investigative Site JP302, Sendai-shi, Not set

Investigative Site JP309, Shinjuku-ku, Not set

Investigative Site NL302, Breda, Not set

Investigative Site NL303, Groningen, Not set

Investigative Site NL301, Rotterdam, Not set

Investigative Site PL203, Lublin, Not set

Investigative Site PL304, Ostrowiec Swietokrzyski, Not set

Investigative Site PL200, Rzeszow, Not set

Investigative Site PL201, Warszawa, Not set

Investigative Site PL202, Warszawa, Not set

Investigative Site PL301, Wroclaw, Not set

Investigative Site PL302, Wroclaw, Not set

Investigative Site ES203, Alicante, Not set

Investigative Site ES302, Badalona, Not set

Investigative Site ES303, Barcelona, Not set

Investigative Site ES301, Granada, Not set

Investigative Site ES202, Las Palmas de Gran Canaria, Not set

Investigative Site ES204, Madrid, Not set

Investigative Site ES201, Madrid, Not set

Investigative Site ES205, Madrid, Not set

Investigative Site ES305, Madrid, Not set

Investigative Site ES200, Manises, Not set

Investigative Site ES300, Pontevedra, Not set

Investigative Site ES304, Santiago de Compostela, Not set

Investigative Site GB202, Birmingham, Not set

Investigative Site GB200, Dudley, Not set

Investigative Site GB201, Leeds, Not set

Investigative Site GB204, London, Not set

Investigative Site GB203, Salford, Not set

Conditions: Hidradenitis Suppurativa (HS)

Learn More ›

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

NCT06855498

Recruiting

Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/30/2025

Locations: Investigative Site US086, Birmingham, Alabama +341 locations

Investigative Site US086, Birmingham, Alabama

Investigative Site US098, Montgomery, Alabama

Investigative Site US004, Phoenix, Arizona

Investigative Site US047, Scottsdale, Arizona

Investigative Site US124, Scottsdale, Arizona

Investigative Site US115, Tucson, Arizona

Investigative Site US045, Fort Smith, Arkansas

Investigative Site US110, Hot Springs, Arkansas

Investigative Site US009, Rogers, Arkansas

Investigative Site US076, Fountain Valley, California

Investigative Site US077, Fremont, California

Investigative Site US071, Huntington Beach, California

Investigative Site US020, Laguna Niguel, California

Investigative Site US036, Los Angeles, California

Investigative Site US067, Los Angeles, California

Investigative Site US060, Northridge, California

Investigative Site US037, Oakland, California

Investigative Site US089, Santa Monica, California

Investigative Site US080, Sherman Oaks, California

Investigative Site US129, Aventura, Florida

Investigative Site US116, Boca Raton, Florida

Investigative Site US002, Boca Raton, Florida

Investigative Site US035, Brandon, Florida

Investigative Site US087, Cape Coral, Florida

Investigative Site US062, Coral Gables, Florida

Investigative Site US084, Coral Gables, Florida

Investigative Site US017, Hialeah, Florida

Investigative Site US019, Hollywood, Florida

Investigative Site US090, Hollywood, Florida

Investigative Site US041, Maitland, Florida

Investigative Site US044, Margate, Florida

Investigative Site US072, Miami Lakes, Florida

Investigative Site US079, Miami Lakes, Florida

Investigative Site US015, Miami, Florida

Investigative Site US023, Miami, Florida

Investigative Site US059, Miami, Florida

Investigative Site US029, Ocala, Florida

Investigative Site US133, Tampa, Florida

Investigative Site US005, Tampa, Florida

Investigative Site US001, Tampa, Florida

Investigative Site US066, West Palm Beach, Florida

Investigative Site US070, West Palm Beach, Florida

Investigative Site US051, Marietta, Georgia

Investigative Site US103, Sandy Springs, Georgia

Investigative Site US100, Stonecrest, Georgia

Investigative Site US125, Chicago, Illinois

Investigative Site US093, Chicago, Illinois

Investigative Site US049, Skokie, Illinois

Investigative Site US039, West Dundee, Illinois

Investigative Site US112, Clarksville, Indiana

Investigative Site US108, Indianapolis, Indiana

Investigative Site US008, Indianapolis, Indiana

Investigative Site US064, West Lafayette, Indiana

Investigative Site US056, Bowling Green, Kentucky

Investigative Site US012, Baton Rouge, Louisiana

Investigative Site US057, New Orleans, Louisiana

Investigative Site US111, Baltimore, Maryland

Investigative Site US038, Baltimore, Maryland

Investigative Site US099, Glenn Dale, Maryland

Investigative Site US053, Marriottsville, Maryland

Investigative Site US101, Rockville, Maryland

Investigative Site US127, Rockville, Maryland

Investigative Site US134, Beverly, Massachusetts

Investigative Site US030, Boston, Massachusetts

Investigative Site US048, Needham, Massachusetts

Investigative Site US061, Ann Arbor, Michigan

Investigative Site US114, Auburn Hills, Michigan

Investigative Site US120, Detroit, Michigan

Investigative Site US014, Fort Gratiot, Michigan

Investigative Site US091, Troy, Michigan

Investigative Site US128, Troy, Michigan

Investigative Site US042, Waterford, Michigan

Investigative Site US011, Minneapolis, Minnesota

Investigative Site US088, Saint Joseph, Missouri

Investigative Site US016, Saint Louis, Missouri

Investigative Site US007, Portsmouth, New Hampshire

Investigative Site US121, Hackensack, New Jersey

Investigative Site US118, Albuquerque, New Mexico

Investigative Site US082, East Syracuse, New York

Investigative Site US123, East Syracuse, New York

Investigative Site US040, Kew Gardens, New York

Investigative Site US034, New York, New York

Investigative Site US081, New York, New York

Investigative Site US065, New York, New York

Investigative Site US075, New York, New York

Investigative Site US050, Rochester, New York

Investigative Site US131, Stony Brook, New York

Investigative Site US031, Chapel Hill, North Carolina

Investigative Site US028, Bexley, Ohio

Investigative Site US055, Boardman, Ohio

Investigative Site US025, Cincinnati, Ohio

Investigative Site US073, Columbus, Ohio

Investigative Site US033, Columbus, Ohio

Investigative Site US130, Dayton, Ohio

Investigative Site US117, Dublin, Ohio

Investigative Site US085, Oklahoma City, Oklahoma

Investigative Site US018, Portland, Oregon

Investigative Site US074, Philadelphia, Pennsylvania

Investigative Site US069, Plymouth Meeting, Pennsylvania

Investigative Site US119, Yardley, Pennsylvania

Investigative Site US043, Murfreesboro, Tennessee

Investigative Site US052, Arlington, Texas

Investigative Site US021, Bellaire, Texas

Investigative Site US078, Dallas, Texas

Investigative Site US010, Dallas, Texas

Investigative Site US054, Pflugerville, Texas

Investigative Site US058, San Antonio, Texas

Investigative Site US083, San Antonio, Texas

Investigative Site US126, Sugar Land, Texas

Investigative Site US068, Webster, Texas

Investigative Site US122, Murray, Utah

Investigative Site US063, South Jordan, Utah

Investigative Site US027, Norfolk, Virginia

Investigative Site US094, Richmond, Virginia

Investigative Site US132, Mill Creek, Washington

Investigative Site US092, Seattle, Washington

Investigative Site US003, Spokane, Washington

Investigative Site AR006, Buenos Aires, Not set

Investigative Site AR005, Ciudad Autonoma de Buenos Aires, Not set

Investigative Site AR002, Ciudad Autonoma de Buenos Aires, Not set

Investigative Site AR004, Mar Del Plata, Not set

Investigative Site AR003, Rosario, Not set

Investigative Site AR001, San Miguel de Tucuman, Not set

Investigative Site AU003, Kogarah, New South Wales

Investigative Site AU005, Liverpool, New South Wales

Investigative Site AU001, Newcastle, New South Wales

Investigative Site AU010, Sydney, New South Wales

Investigative Site AU007, Wolloongabba, Queensland

Investigative Site AU006, Woolloongabba, Queensland

Investigative Site AU004, Carlton, Victoria

Investigative Site AU002, East Melbourne, Not set

Investigative Site AU008, Fremantle, Not set

Investigative Site AU009, Westmead, Not set

Investigative Site AT002, Graz, Not set

Investigative Site AT004, Innsbruck, Not set

Investigative Site AT001, Vienna, Not set

Investigative Site AT003, Wien, Not set

Investigative Site BE007, Brugge, Not set

Investigative Site BE002, Brussel, Not set

Investigative Site BE001, Gent, Not set

Investigative Site BE004, Gent, Not set

Investigative Site BE003, Liege, Not set

Investigative Site BE006, Loverval, Not set

Investigative Site BE005, Woluwe-saint-lambert, Not set

Investigative Site BG008, Dupnitsa, Not set

Investigative Site BG010, Lovech, Not set

Investigative Site BG012, Pleven, Not set

Investigative Site BG013, Plovdiv, Not set

Investigative Site BG007, Sevlievo, Not set

Investigative Site BG009, Sofia, Not set

Investigative Site BG002, Sofia, Not set

Investigative Site BG006, Sofia, Not set

Investigative Site BG011, Sofia, Not set

Investigative Site BG003, Sofia, Not set

Investigative Site BG001, Sofia, Not set

Investigative Site BG014, Sofia, Not set

Investigative Site BG005, Sofia, Not set

Investigative Site BG004, Stara Zagora, Not set

Investigative Site CA023, Calgary, Alberta

Investigative Site CA008, Calgary, Alberta

Investigative Site CA005, Edmonton, Alberta

Investigative Site CA028, Edmonton, Alberta

Investigative Site CA027, Edmonton, Alberta

Investigative Site CA013, Surrey, British Columbia

Investigative Site CA024, Vancouver, British Columbia

Investigative Site CA003, Winnipeg, Manitoba

Investigative Site CA006, Fredericton, New Brunswick

Investigative Site CA004, Barrie, Ontario

Investigative Site CA030, Cobourg, Ontario

Investigative Site CA011, Hamilton, Ontario

Investigative Site CA025, London, Ontario

Investigative Site CA002, London, Ontario

Investigative Site CA022, Markham, Ontario

Investigative Site CA014, Mississauga, Ontario

Investigative Site CA016, Mississauga, Ontario

Investigative Site CA001, Peterborough, Ontario

Investigative Site CA010, Richmond Hill, Ontario

Investigative Site CA017, Toronto, Ontario

Investigative Site CA018, Toronto, Ontario

Investigative Site CA021, Toronto, Ontario

Investigative Site CA019, Waterloo, Ontario

Investigative Site CA007, Montreal, Quebec

Investigative Site CA020, Quebec City, Quebec

Investigative Site CA026, Quebec City, Quebec

Investigative Site CA009, Saint-jerome, Quebec

Investigative Site CA029, Verdun, Quebec

Investigative Site CA015, Saskatoon, Saskatchewan

Investigative Site CL002, LAS Condes Santiago, Not set

Investigative Site CL003, Santiago, Not set

Investigative Site CL001, Valdivia, Not set

Investigative Site CZ002, Ostrava-poruba, Not set

Investigative Site CZ004, Prague, Not set

Investigative Site CZ003, Prague, Not set

Investigative Site CZ001, Prague, Not set

Investigative Site DK001, Aarhus, Not set

Investigative Site DK002, Roskilde, Not set

Investigative Site FR014, Antony, Not set

Investigative Site FR006, Bordeaux, Not set

Investigative Site FR004, Brest, Not set

Investigative Site FR015, Creteil, Not set

Investigative Site FR002, Dijon, Not set

Investigative Site FR013, Le Mans, Not set

Investigative Site FR009, Lyon, Not set

Investigative Site FR012, Marseille, Not set

Investigative Site FR016, Mulhouse, Not set

Investigative Site FR011, Nantes, Not set

Investigative Site FR008, Nice, Not set

Investigative Site FR010, Paris, Not set

Investigative Site FR005, Reims, Not set

Investigative Site FR018, Romans Sur Isere, Not set

Investigative Site FR007, Rouen Cedex, Not set

Investigative Site FR003, Saint Priest En Jarez, Not set

Investigative Site FR001, Toulouse Cedex 9, Not set

Investigative Site FR017, Toulouse, Not set

Investigative Site DE036, Aachen, Not set

Investigative Site DE025, Bad Bentheim, Not set

Investigative Site DE005, Berlin, Not set

Investigative Site DE026, Berlin, Not set

Investigative Site DE006, Bochum, Not set

Investigative Site DE037, Bonn, Not set

Investigative Site DE024, Buxtehude, Not set

Investigative Site DE023, Chemnitz, Not set

Investigative Site DE013, Darmstadt, Not set

Investigative Site DE019, Darmstadt, Not set

Investigative Site DE004, Dessau-rosslau, Not set

Investigative Site DE027, Dortmund, Not set

Investigative Site DE012, Dresden, Not set

Investigative Site DE014, Dusseldorf, Not set

Investigative Site DE009, Erlangen, Not set

Investigative Site DE011, Frankfurt Am Main, Not set

Investigative Site DE021, Friedrichshafen, Not set

Investigative Site DE010, Gottingen, Not set

Investigative Site DE032, Halle, Not set

Investigative Site DE001, Hamburg, Not set

Investigative Site DE002, Hannover, Not set

Investigative Site DE017, Heidelberg, Not set

Investigative Site DE007, Heidelberg, Not set

Investigative Site DE003, Kiel, Not set

Investigative Site DE033, Leipzig, Not set

Investigative Site DE034, Luebeck, Not set

Investigative Site DE029, Magdeburg, Not set

Investigative Site DE022, Mahlow, Not set

Investigative Site DE015, Mainz, Not set

Investigative Site DE035, Mainz, Not set

Investigative Site DE038, Marburg, Not set

Investigative Site DE008, Merzig, Not set

Investigative Site DE030, Muenchen, Not set

Investigative Site DE028, Oldenburg, Not set

Investigative Site DE031, Tuebingen, Not set

Investigative Site DE018, Witten, Not set

Investigative Site GR001, Athens, Not set

Investigative Site GR002, Athens, Not set

Investigative Site GR003, Thessaloniki, Not set

Investigative Site HU001, Debrecen, Not set

Investigative Site HU002, Szombathely, Not set

Investigative Site IT012, Bari, Not set

Investigative Site IT009, Brescia, Not set

Investigative Site IT001, Catania, Not set

Investigative Site IT007, Chieti, Not set

Investigative Site IT010, L'aquila, Not set

Investigative Site IT011, Milano, Not set

Investigative Site IT005, Milan, Not set

Investigative Site IT008, Naples, Not set

Investigative Site IT013, Perugia, Not set

Investigative Site IT002, Rome, Not set

Investigative Site IT003, Rozzano, Not set

Investigative Site IT004, Torrette DI Ancona, Not set

Investigative Site KR006, Ansan-si, Not set

Investigative Site KR008, Bucheon-si, Not set

Investigative Site KR007, Busan, Not set

Investigative Site KR003, Incheon, Not set

Investigative Site KR004, Jeonju-si, Not set

Investigative Site KR002, Seoul, Not set

Investigative Site KR005, Seoul, Not set

Investigative Site KR001, Yangsan-si, Not set

Investigative Site MX001, Guadalajara, Not set

Investigative Site NL005, Amsterdam, Not set

Investigative Site NL007, Amsterdam, Not set

Investigative Site NL006, Bergen Op Zoom, Not set

Investigative Site NL002, Breda, Not set

Investigative Site NL003, Groningen, Not set

Investigative Site NL001, Rotterdam, Not set

Investigative Site NL004, Veldhoven, Not set

Investigative Site PL013, Cracov, Not set

Investigative Site PL011, Gdansk, Not set

Investigative Site PL009, Gdansk, Not set

Investigative Site PL029, Grodzisk Mazowiecki, Not set

Investigative Site PL016, Katowice, Not set

Investigative Site PL035, Kielce, Not set

Investigative Site PL031, Lublin, Not set

Investigative Site PL002, Lublin, Not set

Investigative Site PL006, Ostrowiec Swietokrzyski, Not set

Investigative Site PL003, Rzeszow, Not set

Investigative Site PL015, Szczecin, Not set

Investigative Site PL028, Szczecin, Not set

Investigative Site PL041, Szczecin, Not set

Investigative Site PL010, Tarnow, Not set

Investigative Site PL030, Torun, Not set

Investigative Site PL014, Warsaw, Not set

Investigative Site PL017, Warszawa, Not set

Investigative Site PL026, Warszawa, Not set

Investigative Site PL007, Warszawa, Not set

Investigative Site PL012, Warszawa, Not set

Investigative Site PL004, Warszawa, Not set

Investigative Site PL027, Warszawa, Not set

Investigative Site PL024, Wrocaw, Not set

Investigative Site PL018, Wroclaw, Not set

Investigative Site PL001, Wroclaw, Not set

Investigative Site PL005, Wroclaw, Not set

Investigative Site PL008, Wroclaw, Not set

Investigative Site PL022, Wroclaw, Not set

Investigative Site ES001, Badalona, Not set

Investigative Site ES010, Barcelona, Not set

Investigative Site ES017, Barcelona, Not set

Investigative Site ES015, Cordoba, Not set

Investigative Site ES003, Granada, Not set

Investigative Site ES013, Granada, Not set

Investigative Site ES006, Las Palmas de Gran Canaria, Not set

Investigative Site ES014, Madrid, Not set

Investigative Site ES008, Madrid, Not set

Investigative Site ES011, Madrid, Not set

Investigative Site ES012, Madrid, Not set

Investigative Site ES004, Manises, Not set

Investigative Site ES022, Pamplona, Not set

Investigative Site ES002, Santiago de Compostela, Not set

Investigative Site ES023, Santiago de Compostela, Not set

Investigative Site ES018, Valencia, Not set

Investigative Site CH003, Bern, Not set

Investigative Site CH001, Buochs, Not set

Investigative Site CH002, Zurich, Not set

Investigative Site GB003, Birmingham, Not set

Investigative Site GB001, Dudley, Not set

Investigative Site GB011, Ipswich, Not set

Investigative Site GB002, Leeds, Not set

Investigative Site GB009, Leicester, Not set

Investigative Site GB013, Liverpool, Not set

Investigative Site GB012, London, Not set

Investigative Site GB005, London, Not set

Investigative Site GB014, London, Not set

Investigative Site GB006, Poole, Not set

Investigative Site GB004, Salford, Not set

Investigative Site GB008, Wolverhampton, Not set

Conditions: Hidradenitis Suppurativa (HS)

Learn More ›

Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

NCT06993610

Recruiting

The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 16 weeks (Period 1) in adults with hidradenitis suppurativa, followed by a 16-week open-label extension period in which all participants will receive tibulizumab (Period 2)

Gender:

ALL

Ages:

Between 18 years and 70 years

Trial Updated:

07/15/2025

Locations: Florida Academic Dermatology Center, Coral Gables, Florida +18 locations

Conditions: Hidradenitis Suppurativa (HS)

Learn More ›

Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%

NCT06645821

Recruiting

The goal of this clinical trial is to learn if drug EVO101 works to treat mild to moderate hidradenitis suppurativa in adults. The main questions it aims to answer are: Does drug EVO101 lower the total number of lesion a participant has from the first visit to the last visit. What medical problems do participants have when applying drug EVO101 Does a participant perceive a change in their hidradenitis suppurativa symptoms based on patient reported outcome questionnaires. Participants will: A... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

12/05/2024

Locations: Virginia Clinical Research, Inc., Norfolk, Virginia

Conditions: Hidradenitis Suppurativa (HS)

Learn More ›

1 - 4 of 4